Ensuring Compliance Against Drug Diversion Act of 2020
United States116th CongressHR-4812House of Representatives
Updated: Nov 18, 2020
Summary
Ensuring Compliance Against Drug Diversion Act of 2020 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.
Bill texts
Timeline
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)
House of Representatives
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)
Motion to reconsider laid on the table Agreed to without objection.
House of Representatives
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Senate